1.55–1.65 (m, 6H), 3.35–3.70 (m, 27H), 4.50–4.70 (m, 4H),
5.15–5.25 (m, 4H), 7.70 (s, 22H), 8.00–9.00 (m, 8H), 9.20–9.65
(m, 2H), 10.70–11.70 (m, 7H), 14.30–15.90 (m, 8H) ppm. 31P
{1H} NMR (CDCl3): δ = 64.05 ppm.
(q, J = 7.2 Hz, 4H), 4.92 (s, 4H), 7.32 (d, J = 8.4 Hz, 4H), 8.15
(d, J = 8.4 Hz, 4H), 9.12 (d, J = 4.8 Hz, 4H), 9.40 (d, J = 4.8
Hz, 4H), 10.27 (s, 2H) ppm.
PPd. Under a nitrogen atmosphere, PH2 (67 mg, 0.10 mmol)
and palladium(II) acetate (227 mg, 1.0 mmol) were stirred in
CHCl3 (100 mL) for 48 h at 40 °C. After removing the solvent,
the residue was purified via chromatography on silica gel
(CHCl3) to give the product in 65% yield (50 mg). MALDI-TOF
HRMS: calcd for [M]+ 770.1371; found 770.1344. 1H NMR
(CDCl3): δ = 1.42 (t, J = 7.2 Hz, 6H), 4.42 (q, J = 7.2 Hz, 4H),
4.93 (s, 4H), 7.31 (d, J = 8.8 Hz, 4H), 8.12 (d, J = 8.8 Hz, 4H),
9.00 (d, J = 4.8 Hz, 4H), 9.27 (d, J = 4.8 Hz, 4H), 10.26 (s, 2H)
ppm.
PH2–PcYb. 0.62 mL of HCl (36%) was added to a solution of
PZn–PcYb (111 mg, 0.054 mmol) in CH2Cl2 (50 mL) under N2.
The reaction mixture was vigorously stirred for 10 min at room
temperature. The solution was washed sequentially with water,
5% NaHCO3 and water, then dried over Na2SO4. After the
solvent was evaporated, the residue was chromatographed on
silica gel using CHCl3 as the eluent. The yield was 100 mg
(93%). MALDI-TOF HRMS: calcd for [M + 1]+ 1994.5064;
1
found 1994.5208. H NMR (400 MHz, CD2Cl2): δ = −6.04 (s,
5H), −2.25 (br, 2H), 1.50–1.65 (m, 6H), 3.20–3.45 (m, 27H),
4.50–4.65 (m, 4H), 5.15–5.20 (m, 4H), 7.67 (s, 22H), 8.40–8.60
(m, 4H), 9.10–9.20 (m, 2H), 9.30–9.50 (m, 2H), 9.70–9.80 (m,
2H), 10.10–10.30 (m, 1H), 10.60–11.00 (m, 3H), 11.40–11.60
(m, 3H), 14.20–15.80 (m, 8H) ppm. 31P{1H} NMR (CDCl3):
δ = 64.31 ppm.
Acknowledgements
The work described in this paper was partially supported by a
grant from the Research Grants Council of the Hong Kong
Special Administrative Region, P.R. China (HKBU 202509) and
a grant from the Hong Kong Baptist University (FRG1/10-11/
011).
PPd–PcYb. Palladium(II) acetate (68 mg, 0.30 mmol) was
added to a solution of PH2–PcYb (60 mg, 0.030 mmol) in
CHCl3 (35 mL) under N2. After stirring for 48 h at 40 °C, the
solvent was evaporated. The residue was purified via chromato-
graphy on silica gel (CHCl3) to give the product in 71% yield
(45 mg). MALDI-TOF HRMS: calcd for [M + 1]+ 2098.3951;
found 2098.4160. 1H NMR (CDCl3): δ = −6.05 (s, 5H),
1.50–1.70 (m, 6H), 3.25–3.45 (m, 27H), 4.55–4.65 (m, 4H),
5.15–5.20 (m, 4H), 7.64 (s, 22H), 8.40–8.60 (m, 4H), 9.10–9.20
(m, 2H), 9.20–9.40 (m, 2H), 9.60–9.80 (m, 2H), 10.00–10.30
(m, 1H), 10.60–11.00 (m, 3H), 11.30–11.60 (m, 3H),
14.30–15.50 (m, 8H) ppm. 31P{1H} NMR (CDCl3): δ =
64.49 ppm.
References
1 R. Bonnett, Chemical Aspects of Photodynamic Therapy, Gordon and
Breach Science Publishers, Amsterdam, 2000.
2 T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel,
M. Korbelik, J. Moan and Q. Peng, J. Natl. Cancer Inst., 1998, 90, 889.
3 I. J. MacDonald and T. J. Dougherty, J. Porphyrins Phthalocyanines,
2001, 5, 105.
4 M. R. Hamblin and T. Hasan, Photochem. Photobiol. Sci., 2004, 3, 436.
5 N. L. Oleinick, R. L. Morris and I. Belichenko, Photochem. Photobiol.
Sci., 2002, 1, 1.
6 K. Lang, J. Mosinger and D. M. Wagnerová, Coord. Chem. Rev., 2004,
248, 321.
7 M. R. Detty, S. L. Gibson and S. J. J. Wagner, J. Med. Chem., 2004, 47,
3897.
8 H. Ke, W.-K. Wong, W.-Y. Wong, H.-L. Tam, C.-T. Poon and F. Jiang,
Eur. J. Inorg. Chem., 2009, 1243.
9 J. Arnbjerg, A. Jiménez-Banzo, M. J. Paterson, S. Nonell, J. I. Borrell,
O. Christiansen and P. R. Ogilby, J. Am. Chem. Soc., 2007, 129, 5188.
10 M. Drobizhev, F. Q. Meng, A. Rebane, Y. Stepanenko, E. Nickel and C.
W. Spangler, J. Phys. Chem. B, 2006, 110, 9802.
11 M. Drobizhev, Y. Stepanenko, Y. Dzenis, A. Karotki, A. Rebane, P.
N. Taylor and H. L. Anderson, J. Am. Chem. Soc., 2004, 126, 15352.
12 I. Hisaki, S. Hiroto, K. S. Kim, S. B. Noh, D. Kim, H. Shinokubo and
A. Osuka, Angew. Chem., Int. Ed., 2007, 46, 5125.
(t-Bu)3Pc. The synthesis of (t-Bu)3Pc followed the same pro-
cedures as for I(t-Bu)3Pc. Phthalonitrile (64 mg, 0.5 mmol), 4-
tert-butylphthalonitrile (462 mg, 2.5 mmol), DBU (0.45 mL),
and dry amyl alcohol (50 mL) were used. Yield: 95.0 mg (28%).
MALDI-TOF HRMS: calcd for [M + 1]+ 683.3611, found
683.3629. 1H NMR (CDCl3): δ = (−4.30)–(−4.00) (m, 2H),
1.64–2.10 (m, 27H), 7.40–9.00 (m, 13H) ppm. UV-vis (toluene):
λmax/nm [log(ε/dm3 mol−1 cm−1)] = 345 (4.76), 600 (4.39), 644
(4.65), 661 (5.09), 697 (5.17).
13 A. Karotki, M. Kruk, M. Drobizhev, A. Rebane, E. Nickel and C.
W. Spangler, IEEE J. Sel. Top. Quantum Electron., 2001, 7, 971.
14 M. K. Kuimova, M. Hoffmann, M. U . Winters, M. Eng, M. Balaz, I.
P. Clark, H. A. Collins, S. M. Tavender, C. J . Wilson, B. Albinsson, H.
L. Anderson, A. W. Parker and D. Phillips, Photochem. Photobiol. Sci.,
2007, 6, 675.
15 K. Ogawa, H. Hasegawa, Y. Inaba, Y. Kobuke, H. Inouye, Y. Kanemitsu,
E. Kohno, T. Hirano, S. Ogura and I. Okura, J. Med. Chem., 2006, 49,
2276.
16 L. Beverina, M. Crippa, M. Landenna, R. Ruffo, P. Salice, F. Silvestri,
S. Versari, A. Villa, L. Ciaffoni, E. Collini, C. Ferrante, S. Bradamante,
C. M. Mari, R. Bozio and G. A. Pagani, J. Am. Chem. Soc., 2008, 130,
1894.
17 K. Ogawa and Y. Kobuke, Anti-Cancer Agents Med. Chem., 2008, 8,
269.
(t-Bu)3PcYb. The synthesis of (t-Bu)3PcYb followed the same
procedures as for [I(t-Bu)3PcYb]. Yb[N(SiMe3)2]3·[LiCl
(THF)3]x (10 mL, 1.6 mmol), (t-Bu)3Pc (68.3 mg, 0.10 mmol),
toluene (20 mL) and NaLOMe (80 mg, 0.17 mmol) were used.
Yield: 85.0 mg (65%). MALDI-TOF HRMS: calcd for [M]+
1
1305.2661, found 1305.2673. H NMR (CDCl3): δ = −6.06 (s,
5H), 3.27–3.40 (m, 27H), 7.59 (s, 18H), 10.70–10.91 (m, 5H),
14.33–15.04 (m, 8H) ppm. 31P{1H} NMR(CDCl3): δ =
64.45 ppm.
PZn. PH2 (67 mg, 0.10 mmol) and zinc acetate (220 mg,
1.0 mmol) were refluxed in CHCl3 (120 mL) for 4 h. After
removing the solvent, the residue was purified via chromato-
graphy on silica gel (CH2Cl2) to give the product in 93% yield
(68 mg). MALDI-TOF HRMS: calcd for [M]+ 728.1613; found
18 V. S.-Y. Lin, P. M. Iovine, S. G. DiMagno, M. J. Therien, S. Malinak and
D. Coucouvanis, Inorg. Synth., 2002, 33, 55.
19 M. K. Kuimova, H. A. Collins, M. Balaz, E. Dahlstedt, J. A. Levitt,
N. Sergent, K. Suhling, M. Drobizhev, N. S. Makarov, A. Rebane, H.
L. Anderson and D. Phillips, Org. Biomol. Chem., 2009, 7, 889.
1
728.1622. H NMR (CDCl3): δ = 1.42 (t, J = 7.2 Hz, 6H), 4.42
4542 | Dalton Trans., 2012, 41, 4536–4543
This journal is © The Royal Society of Chemistry 2012